Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway

<div>Network pharmacology analysis of the KTZG for NAFLD treatment. (a) Compound-target network of KTZG. The network included 42 compounds and 79 proteins, forming 296 edges. (b) PPI network of the identified targets. Node size was positively associated with node degree. (c) KEGG pathway analysis of the targets.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway 